Textbooks and Publications

Textbooks

• Surveillance Manual – Chapter 13: Rotavirus
  Manual for the Surveillance of Vaccine-Preventable Diseases (4th Edition, 2008). Describes the disease, background, importance of rapid identification, importance of surveillance, disease reduction goals, case definition, laboratory testing, reporting, vaccination, enhancing surveillance, case investigation, outbreak investigation, and outbreak control.
• Pink Book's Chapter on Rotavirus (740 KB, 12 pages)
  Epidemiology & Prevention of Vaccine-Preventable Diseases textbook.

Publications

MMWR

• Rotavirus Surveillance — Worldwide, 2009
  MMWR. 2011; 60(16):514-6.
• Recommended immunization schedules for persons aged 0 through 18 years — United States, 2011
  MMWR. 2011; 60(04):1-4.
• Reduction in rotavirus after vaccine introduction — United States, 2000-2009
  MMWR. 2009; 58(41):1146-9.
• Prevention of rotavirus gastroenteritis among infants and children recommendations of the Advisory Committee on Immunization Practices (ACIP)
  MMWR. 2009; 58(RR02):1-25.
• Rotavirus surveillance — worldwide, 2001-2008
  MMWR. 2008; 57(46):1255-7.
• Delayed onset and diminished magnitude of rotavirus activity — United States, November 2007-May 2008
  MMWR. 2008; 57(25):697-700.
• Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy.
  MMWR. 2003; 52(RR16):1-16.

Vaccine Impact and Surveillance

• Cortes JE, Curns AT, Tate JE, Cortese MM, Patel MM, Zhou F, Parashar UD. Rotavirus vaccine and health care utilization for diarrhea in U.S. children. N Engl J Med. 2011;365(12):1108-17.
• Payne DC, Staat MA, Edwards KM, Szilagyi PG, Weinberg GA, et al. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US counties, 2006–2009. Clin Infect Dis. 2011;DOI: 10.1093/cid/cir307
• Tate JE, Cortese MM, Payne DC, Curns AT, Yen C, Esposito DH, et al. Uptake, impact, and effectiveness of rotavirus vaccination in the United States. Pediatr Infect Dis J. 2011;30(Suppl 1):S56-S60.
• Yen C, Tate JE, Wenk JD, Harris JM 2nd, Parashar UD. Diarrhea-associated hospitalizations among United States children over 2 rotavirus seasons after vaccine introduction. Pediatrics. 2011;127:e9–e15.
• Cortese MM, Tate JE, Simonsen L, Edelman L, Parashar UD. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases. Pediatr Infect Dis J. 2010;29(6):489-94.
• Curns AT, Steiner CA, Barrett M, Hunter K, Wilson E, Parashar UD. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis. 2010;201(11):1617-24.
• Payne DC, Szilagyi P, Staat MA, Edwards K, Hall CB, Gentsch JR, et al. Secular variation in United States rotavirus disease rates and serotypes — implications for assessing the rotavirus vaccination program. Pediatr Infect Dis J. 2009;28(11):948–53.
• Tate JE, Panozzo CA, Payne DC, Patel MM, Cortese MM, Fowlkes AL, et al. Decline and Change in Seasonality of US Rotavirus Activity After the Introduction of Rotavirus Vaccine. Pediatrics. 2009; 124(2):465-71.
• Payne DC, Staat MA, Edwards KM, Szilagyi PG, Gentsch JR, Stockman LJ, et al. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics. 2008;122(6):1235-43.

Top of Page

Vaccine Effectiveness

• Boom JA, Tate JE, Sahni LC, Rench MA, Hull JJ, Gentsch JR, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010;125(2):e199-207.
• Wang FT, Mast TC, Glass RJ, Loughlin J, Seeger JD. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States. Pediatrics. 2010;125(2):e208-13.
• Ruiz-Palacios G, Pérez-Schael I, Velázquez F, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11-22.
• Vesikari T, Matson D, Dennehy P, Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23-33.

Global

• Steele A, Neuzil KM, Parashar U, eds. Rotavirus vaccines for children in developing countries. Vaccine. 2012;30(S1):A1-A196.
• Patel MM, López-Collada VR, Bulhões MM, De Oliveira LH, Bautista Márquez A, Flannery B, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med. 2011;364(24):2283-92.
• Patel MM, Steele D, Gentsch JR, Wecker J, Glass RI, et al. Real-world impact of rotavirus vaccination. Infect Dis J. 2011;30(1 Suppl):S1-5. DOI: 10.1097/INF.0b013e3181fefa1f
• Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dalls MJ, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet. 2010(9741);376:615-23.
• Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376(9741):606-14.
• Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010;375(9730):1969-87.
• de Palma O., Cruz L., Ramos H., de Baires A., Villatoro N., Pastor D., et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ. 2010;340:c2825.
• Jiang B, Patel M, Parashar U. Rotavirus vaccines for global use: what are the remaining issues and challenges? Hum Vaccin. 2010;6:425–7.
• Richardson, V, Hernandez-Pichardo, J, Quintanar-Solares, M, Esparza-Aguilar, M, Johnson, B, Gomez-Altamirano CM, Parashar UD, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med. 2010;362:299-305.
• Madhi, SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362:289-98.
• World Health Organization. Manual of rotavirus detection and characterization methods [PDF-3.8MB, 156 pages]. 2009. IVB/08.17.
• Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis, 2009;200(Suppl 1): S9–S15.
• World Health Organization. Meeting of the immunization Strategic Advisory Group of Experts, April 2009—conclusions and recommendations [PDF-495 KB, 24 pages]. Wkly Epidemiol Rec. 2009;84(23):220–36.
• World Health Organization. Rotavirus vaccines: an update[PDF-746 KB, 8 pages]. Wkly Epidemiol Rec. 2009;84(51–2):533–40.
• Patel M, Pedreira C, De Oliveira LH et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA. 2009;301(21):2243-51.
• World Health Organization. Conclusions and recommendations from the immunization Strategic Advisory Group: rotavirus vaccines [PDF-182 KB, 12 pages]. Wkly Epidemiol Rec. 2006;81(1):8.

Top of Page